When was Kove founded?

Kove was founded in 2019 and raised its 1st funding round 7 years after it was founded.

Where is Kove located?

Kove is headquartered in Zurich, Switzerland.

Who is the current CEO of Kove?

Yannick Devaud of Kove. They have also founded 1 company.

How many employees does Kove have?

As of Jul 31, 2026, the latest employee count at Kove is 7.

Is Kove a funded company?

Kove is a funded company, having raised a total of $***** in its 1st and only funding round, a Angel round on Aug 31, 2026.

When was the latest funding round of Kove?

Kove's latest funding was a $***** Angel round on Aug 31, 2026, with participation from 0 investor.

Where does Kove rank among its competitors?

Kove ranks 7th amongst 30 active competitors, of which 9 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Materna Medical, which secured $5M in Jul, 2026.

Who are the top competitors of Kove?

Kove's top competitors include Materna Medical, CooperSurgical and Novocuff. Among them, Kove secured the most recent funding round in August, 2026.

Kove - 2026 Company Profile, Team, Funding & Competitors

Company Details

Kove provides a surgical device for fetal treatment by fetoscopic intervention device. The company offers a catheter that is used in fetoscopy as an entry site and apply the patch after the intervention is done. The technology helps to reduce the risk of preterm birth-related complications and death. The premature prelabour of fetal membranes and fetoscopic interventions are also used to sealing the defect created by the insertion of the fetoscopes inside the amniotic cavity.

Website: kovemedical.com
Social

Key Metrics

Founded Year

2019

Location

Zurich, Switzerland

Stage

Seed

Total Funding

$1.97M in 1 round

Latest Funding Round

Angel, Aug 31, 2026, $*****

Investors

Venturelab & 3 more

Ranked

7^th among 30 active competitors

Employee Count

7 as on Jul 31, 2026

Similar Companies

Materna Medical & 34 more

View Kove's full profile

Kove has raised a total funding of $1.97M over 1 round. Kove has 4 institutional investors.

Here is the list of recent funding rounds of Kove:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 31, 2026	3048157	Angel	2132645	3147450	3908053	6401729

Access funding benchmarks and valuations. Sign up today!

View details of Kove's funding rounds and investors

The founders of Kove is Yannick Devaud. Yannick Devaud is the CEO of Kove.

Here are the details of Kove's key team members:

Yannick Devaud: Founder & CEO of Kove.
Contact Info: 1 email address

View details of Kove's Founder profiles and Board Members

Kove's employee count trend

Kove has 7 employees as of Jul 26. Here is Kove's employee count trend over the years:

Uncover Kove's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kove include Materna Medical, CooperSurgical and Novocuff. Here is the list of Top 10 competitors of Kove, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Materna Medical 2010, Mountain View (United States), Series B	Provider of medical devices for women's pelvic health	$62.7M	InnovaHealth Partners, Wavemaker 360 & 17 others	62/100
2nd	CooperSurgical 1990, Trumbull (United States), Unfunded	Provider of devices and surgical instruments for pregnancy	-	-	44/100
3rd	Novocuff 2021, San Luis Obispo (United States), Series A	Developer of medical device to prevent infant mortality caused by preterm birth complications	$28M	Laerdal Million Lives Fund, AXA Investment Managers ... & 6 others	42/100
4th	Clinical Innovations 1993, Murray (United States), Acquired	Medical technology company focused on restoring dignity through innovative diagnostic solutions	-	Curewell Capital, Meadu Capital Partners & 2 others	41/100
5th	NUA Surgical 2018, Galway (Ireland), Series A	Developer of specialised surgical retractor to make C-Sections a safer	$6.86M	EQT, TMC Venture Fund & 4 others	41/100
6th	PeriPear 2024, Oxford (United Kingdom), Unfunded	Developer of a wearable device designed to reduce perineal tearing	-	-	35/100
7th	Kove 2019, Zurich (Switzerland), Seed	Provider of surgical device for fetal treatment by fetoscopic interventions	$1.97M	Venturelab, Venture Kick & 2 others	31/100
8th	Novate Medical 2010, New Orleans (United States), Acquired	Obstetric device to prevent infection	-	Seroba Life Sciences, Omnes Capital & 2 others	30/100
9th	Reia 2017, New York City (United States), Funding Raised	Developer of non-surgical device for pelvic prolapse	-	MassChallenge, HHS	30/100
10th	Safe Obstetric Systems 2006, Shenfield (United Kingdom), Acquired	Developer of a device to make the cesarean section safer	-	-	29/100